BUZZ-Kenvue falls; Trump eyes 'important' announcement on autism findings Monday

Reuters
Sep 22
BUZZ-Kenvue falls; Trump eyes 'important' announcement on autism findings Monday

** Shares of Tylenol maker Kenvue KVUE.N fall 3.1% to $17.78 premarket

** U.S. President Donald Trump said on Saturday his administration would make announcement about its autism findings on Monday, declining to offer specifics

** The Wall Street Journal reported earlier this month that Health Secretary Robert F. Kennedy Jr. plans to announce that use of KVUE's popular over-the-counter pain medication Tylenol by pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use

** Kenvue has previously said it continues to believe that taking acetaminophen - the active ingredient in Tylenol - does not cause autism

** Up to last close, stock down 14.1% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10